Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dichlorvos is an organophosphate insecticide primarily used for the control of household pests and protection of stored products from insects. It has also been used in veterinary medicine to control parasites in pets and livestock. The compound acts as an irreversible inhibitor of acetylcholinesterase, leading to accumulation of acetylcholine at nerve synapses and disruption of normal nerve function. This mechanism results in neurotoxic effects that can be fatal at high exposures. Dichlorvos has been available since 1961 but its use is controversial due to environmental persistence and toxicity concerns; it is classified by the EPA as a probable human carcinogen based on animal studies[1][3][4][5]. Its main uses are now restricted or banned in many countries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dichlorvos.